Basic Information
Basic information for ITGA9-AS1-226-32aa
Peptide Name ITGA9-AS1-226-32aa
Genome Position chr3:37795319-37795414[-]
Species Human
Peptide Sequence MWEYKEKAPVRGLRGKWFPQVRSTLSVRKEVV
Peptide Length 32
Unique No (ITGA9-AS1-224-32aa,ITGA9-AS1-229-32aa)
Grand Average of Hydropathicity -0.6844
Relative Molecular Mass 4420.05
Experimental Evidences no
lncRNA ID/Name ENSG00000235257;ITGA9-AS1
Transcript ID/Name ENST00000660349;ITGA9-AS1-226
Transcript Length 2137
Coding Ability 0.4577
DNA Sequence Corresponding to Peptide ATGTGGGAGTACAAGGAAAAAGCCCCCGTGAGAGGGCTGCGGGGGAAATGGTTTCCCCAGGTTAGATCCACGCTTTCAGTAAGAAAGGAGGTGGTG
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :